-
Mashup Score: 66How I treat newly diagnosed acute lymphoblastic leukemia | Published in Clinical Hematology International - 2 day(s) ago
By Sebastian Giebel. Treatment algorithms differ for adult patients with Philadelphia-negative (Ph-) and Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL).
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 21
By Helen Cashman, Andrew J Wilson & 4 more. Our patient was a 36-year-old female who presented to hospital at 33 weeks pregnant with symptomatic COVID-19 infection.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 62How I treat newly diagnosed acute lymphoblastic leukemia | Published in Clinical Hematology International - 4 day(s) ago
By Giebel Sebastian. Treatment algorithms differ for adult patients with Philadelphia-negative (Ph-) and Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL).
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 24For Authors | Clinical Hematology International - 12 day(s) ago
Clinical Hematology International is an open-access journal supported by the International Academy for Clinical Hematology
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 44Overview of approved CAR-T products and utility in clinical practice | Published in Clinical Hematology International - 21 day(s) ago
By Shakthi T Bhaskar, Bhagirathbhai Dholaria & 3 more. Since the first (CAR) T-cell product received FDA approval in 2017, studies have been completed that have led to approvals of CAR T-cells to treat a variety of malignancies.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 21
By Tanvi H. Patel, Ramya Bachu & 13 more. Given anxiety’s detrimental effects, our findings emphasize the importance of incorporating psychosocial assessments to optimize care for MGUS and SMM patients.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 44Overview of approved CAR-T products and utility in clinical practice | Published in Clinical Hematology International - 24 day(s) ago
By Shakthi T Bhaskar, Bhagirathbhai Dholaria & 3 more. Since the first (CAR) T-cell product received FDA approval in 2017, studies have been completed that have led to approvals of CAR T-cells to treat a variety of malignancies.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 26Multidisciplinary Management of Morbidities Associated with Chronic Graft-Versus-Host Disease | Published in Clinical Hematology International - 26 day(s) ago
By Rahul Shah, Danielle Murphy & 13 more. We highlight the myriad impacts of cGVHD including and beyond the traditional organ systems captured by the National Institutes of Health Consensus Criteria, including iatrogenic complications of long-term immunosuppression.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 44
By Minoo Battiwalla, Ju-Hsien Chao & 17 more. Most cancer patients receive care in the community, yet few studies have evaluated the effectiveness of clinical programs outside of academic or National Cancer Institute (NCI)-designated cancer centers.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Deep Learning in Hematology: From Molecules to Patients | Published in Clinical Hematology International - 1 month(s) ago
By Jiasheng Wang. Deep learning, a subfield of machine learning, has made remarkable strides across various aspects of medicine. This review examines DL’s applications in hematology, spanning from molecular insights to patient care.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
How would I like to treat newly diagnosed Ph-negative ALL? https://t.co/wwqEZEzPLs #leusm https://t.co/rRhmFheYcA